HKSE - Delayed Quote HKD
GRAND PHARMA (0512.HK)
8.310
+0.120
+(1.47%)
As of 2:20:54 PM GMT+8. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 2.15B | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Tang (Wei Kun) Chairman of the Board | Acquisition at price 0.77 per share. | Direct | 53,157 | Mar 25, 2025 |
| Tang (Wei Kun) Chairman of the Board | Acquisition at price 0.60 per share. | Direct | 29,965 | Jun 28, 2024 |
| Tang (Wei Kun) Chairman of the Board | Acquisition at price 0.61 per share. | Direct | 67,364 | Jun 20, 2024 |
| Zhou (Chao) Chief Executive Officer | Acquisition at price 0.60 per share. | Direct | 25,682 | Jun 6, 2024 |
| Tang (Wei Kun) Chairman of the Board | Acquisition at price 0.62 per share. | Direct | 34,619 | May 24, 2024 |
| Zhou (Chao) Chief Executive Officer | Acquisition at price 0.65 per share. | Direct | 31,991 | May 10, 2024 |
| Tang (Wei Kun) Chairman of the Board | Acquisition at price 0.63 per share. | Direct | 62,540 | May 9, 2024 |
| Tang (Wei Kun) Chairman of the Board | Acquisition at price 0.50 per share. | Direct | 47,424 | Apr 19, 2024 |
| Zhou (Chao) Chief Executive Officer | Acquisition at price 0.50 per share. | Direct | 51,005 | Apr 8, 2024 |
| Tang (Wei Kun) Chairman of the Board | Acquisition at price 0.52 per share. | Direct | 31,008 | Apr 3, 2024 |
| Tang (Wei Kun) Chairman of the Board | Acquisition at price 0.52 per share. | Direct | 52,070 | Mar 26, 2024 |
| Zhou (Chao) Chief Executive Officer | Acquisition at price 0.52 per share. | Direct | 25,626 | Mar 22, 2024 |
| Zhou (Chao) Chief Executive Officer | Acquisition at price 0.52 per share. | Direct | 29,108 | Mar 21, 2024 |
| Tang (Wei Kun) Chairman of the Board | Acquisition at price 0.49 per share. | Direct | 48,760 | Mar 20, 2024 |
Related Tickers
PHO.OL Photocure ASA
50.30
+0.40%
2877.HK China Shineway Pharmaceutical Group Limited
7.160
+0.99%
0867.HK CMS
8.250
+0.86%
6896.HK Golden Throat Holdings Group Company Limited
5.390
+5.48%
2186.HK Luye Pharma Group Ltd.
1.940
-0.51%
3933.HK The United Laboratories International Holdings Limited
13.160
+1.70%
1681.HK CONSUN PHARMA
9.470
-1.04%
3692.HK Hansoh Pharmaceutical Group Company Limited
23.350
+3.32%
YIHCF YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
0.5500
0.00%
2552.HK Hua Medicine (Shanghai) Ltd.
2.090
+1.46%